3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.

Source:http://linkedlifedata.com/resource/pubmed/id/16420048

J. Med. Chem. 2006 Jan 26 49 2 625-36

Download in:

View as

General Info

PMID
16420048